Drug recall · November 29, 2017
Lorazepam Tablets recall
Why: Labeling: Label Error on Declared Strength. Bottle labeled as 0.5 mg tablets contained 1mg tablets of lorazepam
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Lorazepam Tablets, USP CIV, 0.5 mg, 500-count bottle, Rx Only, Manufactured by: Leading Pharma, LLC Fairfield, NJ 07004 NDC 69315-904-05
- Lots / codes
Lot #E00717
- Quantity
- 2952 500-count bottles
- Company
- Leading Pharma, LLC, Fairfield, NJ
- Distribution
- Nationwide in the USA
- Initiated
- September 28, 2017 · Voluntary: Firm initiated
- Classified
- November 20, 2017
- Reported
- November 29, 2017
- Ended
- September 21, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Lorazepam
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.